Dr. Alex Zhavoronkov, founder and co-CEO of Insilico Medicine, will be discussing the use of AI and robotics in bioscience innovation at London Tech Week and Founders Forum Global 2024. He will also be speaking about the impact of AI on drug discovery and commercialization.
